NewslettersNeural Cell NewsRestoration of Striatal Neuroprotective Pathways by Kinase Inhibitor Treatment of Parkinson’S Disease-Linked LRRK2-Mutant MiceBy Noshin Noorjahan - July 2, 2025064Researchers tested the leucine-rich repeat kinase 2 (LRRK2) inhibitor MLi-2 in a mouse model of early stage, LRRK2 mutation–associated Parkinson’s disease.[Science Signaling]AbstractPress Release